{"id":1909,"date":"2021-02-24T13:11:36","date_gmt":"2021-02-24T13:11:36","guid":{"rendered":"https:\/\/meditrial.net\/clinical-trials-where\/?page_id=1909"},"modified":"2022-07-07T18:22:42","modified_gmt":"2022-07-07T18:22:42","slug":"poland","status":"publish","type":"page","link":"https:\/\/meditrial.net\/clinical-trials-where\/eastern-europe\/poland\/","title":{"rendered":"Poland"},"content":{"rendered":"
<\/span><\/div>

Polish Approval Process<\/h2>\n

Poland has been an EU member since 2004. The legislation almost fully correlates with the EU directives, including the Drug Law.
\nThe realistic study start-up time is 5 months.<\/p>\n

Polish Recruitment Potential<\/h2>\n

The population of Poland is 38 million.
\nPatients are willing to participate in clinical studies, which makes the recruitment rates much higher than in Western Europe or the USA.<\/p>\n

Investigators and Sites<\/h2>\n

For many years, Meditrial has helped sponsors to conduct clinical trials in Poland. There are over 1,200 sites (including more than 50 university hospitals and medical institutes). Public and private hospitals and clinics are well equipped and offer the highest standard of treatment and diagnostics. In addition, the presence of well-educated researchers providing high-quality data is one of the main factors that make Poland an attractive place to conduct clinical trials.<\/p>\n<\/div><\/div>